Targeted disruption of the c-src proto-oncogene in mice has shown that src expression is required for normal bone resorption, since the src-deficient mutants develop osteopetrosis. To evaluate the mechanisms by which src-deficiency affects osteoclast function, we treated src-deficient mice with the stimulants of bone resorption, IL-1, parathyroid hormone, and parathyroid hormone-related protein, and analyzed the effects by quantitative bone histomorphometry and electron microscopy. Increased numbers of multinucleated cells with the morphological characteristics of osteoclasts appeared on bone surfaces, but these cells did not form ruffled borders or normal resorption lacunae. To confirm these in vivo findings, we cultured src-mutant bone marrow cells on dentine slices in the presence of 1,25 dihydroxyvitamin D3. Increased numbers of multinucleated cells were formed, but unlike normal murine bone marrow cells, they did not form resorption pits. These results indicate that osteoclasts appear in the absence of pp60c-src, but that pp60c-src expression is required for mature osteoclasts to form ruffled borders and resorb bone.
Introduction
Targeted mutations introduced into the germ line of mice after homologous recombination in embryonic stem cells allow new insights into the functions of individual gene products in the animal. Using this technology, it was shown recently that several independent mutations in the c-src gene cause osteopetrosis in mice ( 1 ), the disease characterized by impairment of the formation of normal bone marrow cavities (2) . The best char-acterized animal model of the human disease is the op variant in which there is a point mutation in the coding region of macrophage-colony stimulating factor (M-CSF)' (3) . In this strain of mice, there is a failure in formation of osteoclasts (4) . In contrast, examination ofthe behavior ofosteoclasts in src-deficient mice both in Vitro and in vivo revealed that multinucleated cells formed on bone surfaces, but they did not form Howship's lacunae. These results show that expression ofpp60' is not required for the formation of osteoclasts, but rather for mature osteoclasts to resorb bone.
Methods
Initially, we performed detailed histomorphometric examination of humeri and vertebrae of untreated src-deficient (src-) mutant and normal wild type (WT) mice aged 6-8 wk. The src-mutant mice (8-12 g) were smaller than the wild type mice ( 16-20 g ). All bone samples were fixed in 10% buffered formalin, decalcified in 14% EDTA, and embedded in paraffin. The following variables were measured in representative 3-Mgm thick sagittal sections cut through the vertebrae using a Bioquant Image Analysis System (R & M Biometrics, Nashville, TN) and a digitizing tablet along with a light microscope and a drawing tube attachment: cartilaginous end plate thickness, primary (10) The posterior halves of the calvariae were fixed, decalcified, and processed in the same manner as the vertebrae and the following variables were measured on representative 3-,gm thick sections: osteoclast numbers within the bone marrow cavities (expressed per square millimeter of the total bone area, i.e., the bone and bone marrow between the outer and inner periosteal surfaces); the osteoclast surface, i.e., the extent ofosteoclasts along the interface surface between bone and bone marrow (expressed as a percentage of the interface, and includes resorbing and nonresorbing osteoclasts; the inactive eroded surface, i.e., the extent ofthe bone surface that has been eroded by osteoclasts but is no longer covered by them; and the mean osteoclast resorption depth, i.e., the average depth that each osteoclasts erodes into the bone matrix from the preexisting bone surface. The position ofthe preexisting bone surface overlying each osteoclast is estimated by drawing a line between the edges of the unresorbed bone surface on either side of each resorption lacuna, such that the line maintains the typical concavity of bone marrow spaces in the calvaria. The distance between this line and the bone surface beneath each osteoclast is measured and the sum of these distances in each section is divided by the number of osteoclasts. We chose to assess the resorption capacity of the osteoclasts directly using this method, rather than by measuring resorption-related changes in the bone matrix area, because there is a wide range in the porosity ofthe normal calvaria, and the period of observation to observe a significant effect on bone volume (72 h) was short.
To examine the ultrastructural appearance of the osteoclasts, the anterior halves of the calvariae of the mice treated with PTH-rP and IL-1 were fixed in 4% formaldehyde and 1% glutaraldehyde in phosphate buffer. The specimens from the PTH-rP-treated mice were decalcified in 14% EDTA before embedding in Poly-Bed 812 (Polysciences Inc., Warrington, PA) but those from the IL-l-treated mice were embedded undecalcified and ultrathin sections from all specimens were examined in a JEOL JEM 100 CS transmission electron microscope.
We studied osteoclast formation in culture by using a modification of mouse bone marrow long-term cultures described by Takahashi et al. (9) . Bone cells were isolated from 4-6-wk-old male ICR Swiss mice (Harlan Industries, Indianapolis, IN). Nonadherent marrow cells were suspended in a-MEM supplemented with 10% FCS (Hyclone Laboratories Inc., Logan, UT) and no antibiotics at a final density of 4 x 106 cells/ml. Half a milliliter of cell suspension (2 x 106 cells/well) was inoculated onto sperm whale dentine in 24-well plates (Corning Glass Inc., Corning, NY), and 1,25 dihydroxyvitamin D3 ( 1,25D3) (Hoffman-La Roche, Nutley, NJ) was added to each well at a final concentration of 10-8 M. The cells were fed every 2 d with 0.3 ml of fresh a-MEM with 10% FCS and 10-' M 1,25D3. After 6 d, the cells on the dentine slices were stained for tartrate-resistant acid phosphatase (TRAP) using a commercially available kit (Sigma Chemical Co., St. Louis, MO). TRAP-positive (red-stained) multinucleated (three or more nuclei) cells (TRAP( + )MNC) were counted under light microscopy at a magnification of200. For examination ofresorption lacunae, the slices were sonicated in 0.1 M NaOH to remove the cells and were stained with 0.1% (vol/vol) toluidine blue. Lacunae were examined using light microscopy and the plane area of matrix resorbed was quantitated using a computer-assisted morphometric program on an Olympus image and process analysis system. Data were analyzed by pattern 
Results
The primary spongiosa thickness and bone volumes in the humeri and vertebrae of the src-deficient mutants were greater than those in the wild type mice (Table I) . However, there was no difference in the thickness of the epiphyseal plates of the humeri or ofthe cartilaginous end plates ofthe vertebrae, indicating that there was no major defect in the formation ofcartilage. Osteoclast numbers, expressed per millimeter of the cancellous bone surface in the vertebral bodies, were significantly higher in the mutants than in the wild type mice. However, there was no significant difference in osteoclast numbers expressed per millimeter of the 10 spongiosa bone surface of the humeri in the mutant or wild type mice. These data suggest that the increased amount of bone in the mutant mice may be caused by a defect in the function rather than in the formation of osteoclasts.
In normal wild type mice, PTH, PTH-rP, and IL-1 led to increased osteoclast numbers in the calvariae of the treated animals (Table II) . There was also an increase in response to each of these factors as assessed by the percentage of bone surface eroded by osteoclasts and of the bone surface covered by osteoclasts. In addition, there was an increase in the depth of resorption lacunae under the osteoclasts. IL-1 increased the resorption depth under the osteoclasts even more than PTH or PTH-rP. In src-deficient mice, all three factors caused an increase in osteoclast number and osteoclast surface, comparable with the increase seen in wild type mice (Fig. 1) . However, there was no significant resorption under the osteoclasts or increase in the extent of the inactive eroded surface without osteoclasts in the src-deficient animals (Table II) . Furthermore, the appearance of the osteoclasts in the src-mutant mice differed from that in the wild type mice. Most of these cells were flat and elongated with smooth surfaces and lacked the cytoplasmic ruffling seen in the activated and more rounded osteoclasts in the wild type mice (Fig. 1) . Thus, although increased numbers of osteoclasts appeared on the bone surfaces, they did not resorb the bone matrix.
In the IL-1-treated mice, blood calcium levels in the wild type mice were significantly greater than in the untreated mice, but there was no increase in blood calcium in the src-deficient mice (Table II) . In the PTH-and PTH-rP-treated src-deficient mice, there was a similar increase in blood calcium to that seen in wild type mice treated with these factors. This increase in blood calcium in the src-deficient mice was presumably attributable to the well-known effects ofPTH and PTH-rP on the kidney to increase the reabsorption of calcium from the renal tubules.
Ultrastructural examination of osteoclasts in each of the three specimens from the IL-1-and PTH-rP-treated groups confirmed the absence of ruffled borders, the complex cytoplasmic folds typical of actively resorbing osteoclasts, in the src-mutants but not in the wild type mice (Fig. 2) .
After 6-d culture of bone marrow cells from WT mice on the dentine slices in the presence of 1,25D3, many TRAP( + ) MNCs were formed (Fig. 3) , and these cells formed resorption pits. Comparable numbers of TRAP(+)MNCs were also seen in src-mutant marrow cell cultures. However, TRAP(+)MNC in wild type and src-mutant mice. After cells were removed, the dentine slices were stained with toluidine blue and pit area was measured as described in Methods. Despite the large number ofTRAP(+)MNC present, no resorption pits were seen on the dentine slices on which the src-mutant cells had been cultured. they failed to form resorption pits (Fig. 3) . These in vitro results are consistent with the in vivo findings described above and further support the notion that pp60> expression is crucial for osteoclast function, but not formation.
Discussion
Our findings indicate that the expression of pp6Ocsin is necessary for the formation of normal ruffled borders in activated osteoclasts. Although it is not certain from our studies whether the effect is direct or indirect, the absence of src is clearly associated with a failure of ruffled border formation and impaired osteoclastic bone resorption. Other, as yet undiscovered, factors may also be necessary. The absence of these or pp6Oc ould be responsible for the failure of ruffled border formation that has been observed in some other forms of osteopetrosis in humans and animals (2) . Little is known about the regulation ofthe formation ofruffled borders in osteoclasts. However, it is likely that reorganization of cytoskeletal proteins, such as actin, a-actinin, talin, and tubulin, takes place in activated osteoclasts (10), and tubulin has been shown to be a substrate for pp6O0 in normal brain cells (11, 12) . Tubulin, vinculin, talin, and the transmembrane receptor for fibronectin are substrates for pp60v in Rous sarcoma virus transformed cells, and some of these are localized to sites of cytoplasmic ruffling ( 13) . Thus, the absence of ruffled border formation in the osteoclasts of src-mutant mice may be related to defective tyrosine phosphorylation of cytoskeletal proteins. Together with a recent preliminary report of the detection of pp60O1' expression in chicken osteoclasts ( 14) , this suggests that the major defect in the src-deficient mutants may be in the osteoclast. However, osteoblasts have a pivotal role in the control ofbone resorption ( 15 ) , and it remains possible that normal pp60Os " expression is required in these cells for osteoclastic bone resorption to occur.
Recent observations in a naturally occurring murine model ofosteopetrosis indicate that other tyrosine kinases may also be essential for normal osteoclast function. In the op mouse mutation, there is a decrease in the formation of osteoclasts (2) . Thus, this variant of murine osteopetrosis appears to be distinct from the osteopetrosis in src-mutant mice where osteoclast formation is not altered. These mice have impaired expression of M-CSF (3), the colony stimulating factor for cells of the monocyte-macrophage lineage, and the defect can be cured by treatment with M-CSF (4, 16), which is produced in bone marrow by accessory cells (9), but not by bone marrow transplantation. The receptor for M-CSF is c-fms, a receptor tyrosine kinase (17) . Since this variant of osteopetrosis is caused by decreased osteoclast formation, and in the src-deficient mice the defect is not in osteoclast formation, but rather in the capacity of mature osteoclasts to form ruffled borders and resorb bone, these data together show that separate and distinct tyrosine kinases are required for both normal osteoclast generation from hematopoietic progenitor cells and bone resorption by mature osteoclasts.
